As of 2024-12-13, the Relative Valuation of PMV Pharmaceuticals Inc (PMVP) is (22.92) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.57 USD, the upside of PMV Pharmaceuticals Inc based on Relative Valuation is -1560.1%.
The range of the Relative Valuation is (21.46) - (20.03) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.6x - 31.4x | 26.5x |
| Forward P/E multiples | 19.1x - 20.1x | 19.6x |
| Fair Price | (21.46) - (20.03) | (22.92) |
| Upside | -1467.0% - -1375.7% | -1560.1% |
| Date | P/E |
| 2024-12-10 | -1.61 |
| 2024-12-09 | -1.60 |
| 2024-12-06 | -1.60 |
| 2024-12-05 | -1.60 |
| 2024-12-04 | -1.69 |
| 2024-12-03 | -1.62 |
| 2024-12-02 | -1.70 |
| 2024-11-29 | -1.63 |
| 2024-11-27 | -1.61 |
| 2024-11-26 | -1.60 |
| 2024-11-25 | -1.60 |
| 2024-11-22 | -1.62 |
| 2024-11-21 | -1.62 |
| 2024-11-20 | -1.58 |
| 2024-11-19 | -1.60 |
| 2024-11-18 | -1.57 |
| 2024-11-15 | -1.62 |
| 2024-11-14 | -1.61 |
| 2024-11-13 | -1.66 |
| 2024-11-12 | -1.68 |
| 2024-11-11 | -1.76 |
| 2024-11-08 | -1.75 |
| 2024-11-07 | -1.79 |
| 2024-11-06 | -1.67 |
| 2024-11-05 | -1.66 |
| 2024-11-04 | -1.65 |
| 2024-11-01 | -1.64 |
| 2024-10-31 | -1.64 |
| 2024-10-30 | -1.60 |
| 2024-10-29 | -1.66 |
| 2024-10-28 | -1.67 |
| 2024-10-25 | -1.67 |
| 2024-10-24 | -1.67 |
| 2024-10-23 | -1.61 |
| 2024-10-22 | -1.72 |
| 2024-10-21 | -1.60 |
| 2024-10-18 | -1.59 |
| 2024-10-17 | -1.61 |
| 2024-10-16 | -1.61 |
| 2024-10-15 | -1.50 |
| 2024-10-14 | -1.51 |
| 2024-10-11 | -1.50 |
| 2024-10-10 | -1.52 |
| 2024-10-09 | -1.50 |
| 2024-10-08 | -1.49 |
| 2024-10-07 | -1.51 |
| 2024-10-04 | -1.54 |
| 2024-10-03 | -1.49 |
| 2024-10-02 | -1.50 |
| 2024-10-01 | -1.51 |